Telehealth effectiveness for pre-exposure prophylaxis delivery in Brazilian public services: the Combine! Study

被引:5
作者
Grangeiro, Alexandre [1 ,2 ]
do Santos, Lorruan Alves [2 ,5 ]
Estevam, Denize Lotufo [3 ]
Munhoz, Rosemeire [3 ]
Arruda, Erico [4 ]
de Moraes, Renata Amaral [4 ]
Winkler, Lisiane de Quadros [6 ]
Neves, Lis Aparecida de Souza
Santos, Juliane Cardoso Villela [7 ]
Kruppa, Mariele [7 ]
Zucchi, Eliana Miura [8 ]
Escuder, Maria Mercedes [9 ]
Leal, Andrea Fachel [10 ]
Koyama, Mitti Ayako Hara [11 ]
Peres, Maria Fernanda Tourinho [2 ]
Couto, Marcia Thereza [2 ]
Neto, Jose Eluf [2 ]
机构
[1] Univ Sao Paulo, Fac Med, Av Dr Arnaldo,455, BR-01246903 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil
[3] Ctr Referencia & Treinamento DST Aids, Sao Paulo, Brazil
[4] Hosp Sao Jose Doencas Infecciosas, Fortaleza, Brazil
[5] Serv Atencao Especializada Ctr Saude IAPI, Porto Alegre, Brazil
[6] Prefeitura Municipal Ribeirao Preto, Ribeirao Preto, SP, Brazil
[7] Ctr Orientacao & Aconselhamento, Curitiba, Brazil
[8] Univ Catolica Santos, Programa Posgrad Saude Colet, Santos, SP, Brazil
[9] Secretaria Estado Saude Sao Paulo, Inst Saude, Sao Paulo, Brazil
[10] Univ Fed Rio Grande do Sul, Inst Filosofia & Ciencias Humanas, Porto Alegre, Brazil
[11] Kamiyama Consultoria Estat Ltda, Sao Paulo, Brazil
关键词
Brazil; effectiveness; human immunodeficiency virus; pre-exposure prophylaxis; prevention; telehealth; UNITED-STATES; IOWA TELEPREP; CARE; PREVENTION; INITIATION; DIAGNOSIS; MODELS; MEN; SEX;
D O I
10.1002/jia2.26173
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IntroductionPre-exposure prophylaxis (PrEP) delivery based on user needs can enhance PrEP access and impact. We examined whether telehealth for daily oral PrEP delivery could change the indicators of care related to prophylactic use in five Brazilian public HIV clinics (testing centres, outpatient clinics and infectious disease hospitals).MethodsBetween July 2019 and December 2020, clients on PrEP for at least 6 months could transition to telehealth or stay with in-person follow-up. Clients were clinically monitored until June 2021. A desktop or mobile application was developed, comprising three asynchronous consultations and one annual in-person consultation visit. Predictors influencing telehealth preference and care outcomes were examined. The analysis encompassed intent-to-treat (first choice) and adjustments for sexual practices, schooling, age, duration of PrEP use and PrEP status during the choice period.ResultsOf 470 users, 52% chose telehealth, with the adjusted odds ratio (aOR) increasing over time for PrEP use (aOR for 25-months of use: 4.90; 95% CI: 1.32-18.25), having discontinued PrEP at the time of the choice (aOR: 2.91; 95% CI: 1.40-6.06) and having health insurance (aOR: 1.91; 95% CI: 1.24-2.94) and decreasing for those who reported higher-risk behaviour (aOR for unprotected anal sex: 0.51; 95% CI: 0.29-0.88). After an average follow-up period of 1.6 years (95% CI: 1.5-1.7), the risk of discontinuing PrEP (not having the medication for more than 90 days) was 34% lower with telehealth (adjusted hazard ratio: 0.66; 95% CI: 0.45-0.97). When adjusted by mixed linear regression, no differences in adherence (measured by mean medication possession rate) were found between in-person and telehealth (p = 0.486) or at pre- and post-telehealth follow-ups (p = 0.245). Sexually transmitted infections increased between the pre-follow-up and post-follow-up choices and were not associated with in-person or telehealth (p = 0.528). No HIV infections were observed.ConclusionsOur findings indicate that telehealth for PrEP delivery can enhance service rationalization and reinforce the prevention cascade. This approach reduces prophylaxis interruptions and is mainly preferred by individuals with lower demands for healthcare services.
引用
收藏
页数:12
相关论文
共 28 条
[1]   Qualitative accounts of PrEP discontinuation from the general population in Eswatini [J].
Barnighausen, Kate ;
Geldsetzer, Pascal ;
Matse, Sindy ;
Hettema, Anita ;
Hughey, Allison B. ;
Dlamini, Phiwa ;
Mavuso, Mxolisi ;
Fakudze, David ;
Kahn, Kathleen ;
Baernighausen, Till ;
McMahon, Shannon A. .
CULTURE HEALTH & SEXUALITY, 2021, 23 (09) :1198-1214
[2]   Bringing Iowa TelePrEP to Scale: A Qualitative Evaluation [J].
Chasco, Emily E. ;
Shafer, Cody ;
Dillon, Dena M. B. ;
Owens, Seth ;
Ohl, Michael E. ;
Hoth, Angela B. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2021, 61 (05) :S108-S117
[3]   Mixed-Methods Evaluation of the Incorporation of Home Specimen Self-Collection Kits for Laboratory Testing in a Telehealth Program for HIV Pre-exposure Prophylaxis [J].
Chasco, Emily E. ;
Hoth, Angela B. ;
Cho, Hyunkeun ;
Shafer, Cody ;
Siegler, Aaron J. ;
Ohl, Michael E. .
AIDS AND BEHAVIOR, 2021, 25 (08) :2463-2482
[4]   Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017 [J].
Coy, Kelsey C. ;
Hazen, Ronald J. ;
Kirkham, Heather S. ;
Delpino, Ambrose ;
Siegler, Aaron J. .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (02)
[5]   Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil [J].
Grangeiro, Alexandre ;
Couto, Marcia Thereza ;
Peres, Maria Fernanda ;
Luiz, Olinda ;
Zucchi, Eliana Miura ;
de Castilho, Euclides Ayres ;
Estevam, Denize Lotufo ;
Alencar, Rosa ;
Wolffenbuettel, Karina ;
Escuder, Maria Mercedes ;
Calazans, Gabriela ;
Ferraz, Dulce ;
Arruda, Erico ;
Correa, Maria da Gloria ;
Amaral, Fabiana Rezende ;
Villela Santos, Juliane Cardoso ;
Alvarez, Vivian Salles ;
Kietzmann, Tiago .
BMJ OPEN, 2015, 5 (08)
[6]  
Gregson S, 2021, LANCET HIV, V8, pe251, DOI 10.1016/S2352-3018(21)00068-0
[7]   Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study [J].
Grulich, Andrew E. ;
Guy, Rebecca ;
Amin, Janaki ;
Jin, Fengyi ;
Selvey, Christine ;
Holden, Jo ;
Schmidt, Heather-Marie A. ;
Zablotska, Iryna ;
Price, Karen ;
Whittaker, Bill ;
Chant, Kerry ;
Cooper, Craig ;
McGill, Scott ;
Telfer, Barbara ;
Yeung, Barbara ;
Levitt, Gesalit ;
Ogilvie, Erin E. ;
Dharan, Nila J. ;
Hammoud, Mohamed A. ;
Vaccher, Stefanie ;
Watchirs-Smith, Lucy ;
McNulty, Anna ;
Smith, David J. ;
Allen, Debra M. ;
Baker, David ;
Bloch, Mark ;
Bopage, Rohan I. ;
Brown, Katherine ;
Carr, Andrew ;
Carmody, Christopher J. ;
Collins, Kym L. ;
Finlayson, Robert ;
Foster, Rosalind ;
Jackson, Eva Y. ;
Lewis, David A. ;
Lusk, Josephine ;
O'Connor, Catherine C. ;
Ryder, Nathan ;
Vlahakis, Emanuel ;
Read, Phillip ;
Cooper, David A. .
LANCET HIV, 2018, 5 (11) :E629-E637
[8]   Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era [J].
Guaraldi, Giovanni ;
Milic, Jovana ;
Martinez, Esteban ;
Kamarulzaman, Adeeba ;
Mussini, Cristina ;
Waters, Laura ;
Pozniak, Anton ;
Mallon, Patrick ;
Rockstroh, Jurgen K. ;
Lazarus, Jeffrey, V .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) :E1222-E1227
[9]   High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil [J].
Hoagland, Brenda ;
Torres, Thiago S. ;
Bezerra, Daniel R. B. ;
Benedetti, Marcos ;
Pimenta, Cristina ;
Veloso, Valdilea G. ;
Grinsztejn, Beatriz .
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2021, 25 (01)
[10]   Iowa TelePrEP: A Public-Health-Partnered Telehealth Model for Human Immunodeficiency Virus Preexposure Prophylaxis Delivery in a Rural State [J].
Hoth, Angela B. ;
Shafer, Cody ;
Dillon, Dena Behm ;
Mayer, Randy ;
Walton, George ;
Ohl, Michael E. .
SEXUALLY TRANSMITTED DISEASES, 2019, 46 (08) :507-512